Komori
Chordia Therapeutics (190A) · TargetRestated

Delivering new anticancer drugs to patients and creating a society where people can feel hopeful about tomorrow

First written in FY2024-Q3. 3 of 5 entries say "Restated". Latest entry: 2026-10-15.

5entries
3years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024-Q3RaisedFY2024RestatedFY2025-H1 – 2026-10-152024: 220242025: 120252026: 22026
Same theme, other companies
Mission to contribute to cancer patients and healthcareA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-15RestatedEarnings

    「当社は、「日本発」「世界初」のこれまでにない新しい抗がん薬を、一日でも早く患者様のもとに届けることで、『Tomorrow is Another day ~明日に希望を感じる社会~』を実現することを目指しています。」

    新しい抗がん薬を患者に迅速に届け、明日に希望を感じる社会を実現する使命が再確認された。
  2. FY2026-H1RestatedAnnual report

    「We aim to create a society where people can look to tomorrow with hope, “Tomorrow is Another Day,” by delivering unprecedented new anticancer drugs originating in Japan and being developed for the first time anywhere in the world to patients as quickly as possible, even one day sooner.」

    The mission of rapidly delivering new anticancer drugs originating in Japan and being developed for the first time anywhere in the world to patients and creating a society that looks to tomorrow with hope has been reaffirmed.
  3. FY2025-H1RestatedAnnual report

    「We aim to create a society where people can look to tomorrow with hope, “Tomorrow is Another day,” by delivering unprecedented new anticancer drugs to patients as quickly as possible, even one day sooner.」

    The mission of rapidly delivering new anticancer drugs to patients and creating a society that looks to tomorrow with hope has been reaffirmed.
  4. FY2024RaisedAnnual report

    「We aim to create a society where people can look to tomorrow with hope, “Tomorrow is Another Day,” by delivering unprecedented new anticancer drugs originating in Japan and being developed for the first time anywhere in the world to patients as quickly as possible, even one day sooner. Since our founding, we have made creating first-in-class anticancer drugs our mission.」

    The previous mission has been expanded to include the expressions “originating in Japan,” “first in the world,” and “creating first-in-class anticancer drugs,” clarifying the scope of the new drugs being pursued.
  5. FY2024-Q3First statedAnnual report

    「We aim to create a society where people can look to tomorrow with hope, “Tomorrow is Another day,” by delivering unprecedented new anticancer drugs to patients as quickly as possible, even one day sooner.」

    The company’s mission of rapidly delivering new drugs to patients is stated.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Chordia Therapeutics's next results are scheduled for 2026-10-15. Read the earnings preview It last moved in the Earnings of 2026-10-15: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.